Novavax COVID-19 vaccine production set back due to supply shortages – ABC News

Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages, dealing another blow to the federal government’s rollout plans.
Key points:

• Novavax is one of three companies the federal government struck a deal with to distribute COVID-19 vaccines in Australia
• It will need to be imported to Australia because of a lack of capable vaccine manufacturers
• The company has faced difficulties sourcing…

Click here to view the original article.